GT Biopharma Presents Positive Preclinical Data of Tri-specific NK Cell Engager (TriKE) at the 60th American Society of Hematology (ASH) Annual Meeting & Exposition

World News: . []

LOS ANGELES Dec 06 2018 GLOBE NEWSWIRE -- OTCQB GTBP and Euronext Paris GTBPPA GT Biopharma or the "Company"), an immuno-oncology biotechnology company focused on innovative treatments based on the Company's proprietary NK-engager and Bispec...

More news and information about GT Biopharma, Inc.

Published By:

Globe Newswire: 13:05 GMT Thursday 6th December 2018

Published: .

Search for other references to "biopharma" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us